If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Directorate Change

9 Feb 2011 11:15

RNS Number : 9398A
Consort Medical PLC
09 February 2011
 



 

 

 

News Release

 

9 February 2011

 

 

Consort Medical plc

 

Consort Medical announces the appointment of Dr. Lynn Drummond to the Board

 

Consort Medical plc ("Consort") is pleased to announce the appointment of Dr. Lynn Drummond as a Board member, effective today.

 

Dr. Drummond has a strong track record within the life sciences sector, bringing over twenty years of management and advisory experience. Lynn spent 16 years at Rothschild in London most recently as a Managing Director within the investment banking division, with a particular focus on transactions within the healthcare sector. Prior to this she worked in the Cabinet Office in London as Private Secretary to the Chief Scientific Advisor. Lynn is also a non executive director of Alimentary Health in Ireland.

 

Dr. Drummond holds a Bachelor of Science Degree in Chemistry from the University of Glasgow and a PhD in Biochemistry from the University of London. She is also a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Edinburgh.

 

Commenting on Dr. Drummond's appointment, Peter Fellner, Chairman said:

"We are delighted that Lynn is joining Consort as a Board member. Lynn brings a tremendous set of skills and experience to the Board and we look forward to working with her."

 

Dr. Lynn Drummond commented:

"Consort has an established reputation as a leader in pharmaceutical drug delivery systems and I look forward to being a part of this growing business and working with the Board to deliver value for shareholders."

 

 

END

 

Enquiries

Consort Medical plc

Tel: +44 (0) 1442 867920

Jonathan Glenn, Chief Executive Officer

Toby Woolrych, Group Finance Director

Brunswick

Tel: +44 (0) 20 7404 5959

Jon Coles/Justine McIlroy

 

Consort Medical plc is a leader in medical devices for drug delivery and device technologies. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.

 

Consort Medical develops and manufactures metered dose inhaler valves, autoinjectors, needle free injectors, actuators, compliance aids, dry powder devices, disposable facemasks, breathing circuits, video laryngoscopes and laryngeal tubes. The Group has a Head Office in Hemel Hempstead, UK and manufacturing facilities in King's Lynn, Norfolk, and Nelson, Lancashire in the UK, Indianapolis, Indiana and Kent, Ohio in the US. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMGGZMLDGMZM
Date   Source Headline
18th Jul 201410:21 amRNSDirector/PDMR Shareholding
16th Jul 20147:00 amRNSDirector/PDMR Shareholding
14th Jul 20147:00 amRNSDirectorate Change
1st Jul 20143:46 pmRNSTotal Voting Rights
26th Jun 201410:37 amRNSHolding(s) in Company
24th Jun 20144:15 pmRNSHolding(s) in Company
23rd Jun 20144:28 pmRNSDirector/PDMR Shareholding
23rd Jun 20144:23 pmRNSDirector/PDMR Shareholding
19th Jun 20142:42 pmRNSDirector/PDMR Shareholding
17th Jun 20147:00 amRNSFinal results for the year ended 30 April 2014
4th Jun 20147:00 amRNSDirector Declaration
2nd Jun 20143:16 pmRNSBlocklisting Interim Review
22nd May 20147:00 amRNSChange of Adviser
16th May 201410:39 amRNSHolding(s) in Company
13th May 20147:00 amRNSKing Systems Milestone Payment
14th Apr 20144:58 pmRNSBlocklisting Interim Review
3rd Apr 201411:15 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSDirector Declaration
19th Mar 20147:00 amRNSInterim Management Statement
3rd Mar 20149:00 amRNSTotal Voting Rights
6th Feb 201410:24 amRNSHolding(s) in Company
5th Feb 20142:45 pmRNSHolding(s) in Company
3rd Feb 20147:00 amRNSFDA Approval of Development Programme
28th Jan 20149:43 amRNSHolding(s) in Company
3rd Jan 20149:15 amRNSTotal Voting Rights
31st Dec 20139:34 amRNSHolding(s) in Company
4th Dec 20137:00 amRNSInterim results for the six months to 31/10/13
2nd Dec 20134:15 pmRNSBlocklisting Interim Review
2nd Dec 20134:14 pmRNSTotal Voting Rights
28th Nov 20137:00 amRNSBespak Supply Contract Award
20th Nov 20131:37 pmRNSJefferies 2013 Global Healthcare Conference
15th Nov 20131:54 pmRNSDirector Declaration
4th Nov 20133:37 pmRNSHolding(s) in Company
1st Nov 20137:00 amRNSTotal Voting Rights
31st Oct 201312:21 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
14th Oct 20134:09 pmRNSBlocklisting Interim Review
14th Oct 20133:58 pmRNSHolding(s) in Company
11th Oct 201312:08 pmRNSHolding(s) in Company
10th Oct 20133:32 pmRNSHolding(s) in Company
30th Sep 20133:26 pmRNSTotal Voting Rights
27th Sep 201310:17 amRNSDirector/PDMR Shareholding
6th Sep 20131:51 pmRNSHolding(s) in Company
5th Sep 20131:39 pmRNSDirector/PDMR Shareholding
3rd Sep 201310:15 amRNSResult of AGM
2nd Sep 20137:00 amRNSInterim Management Statement
26th Jul 20132:52 pmRNSPosting of Annual Report and Notice of AGM
24th Jul 20132:43 pmRNSDirector/PDMR Shareholding
22nd Jul 20137:00 amRNSBespak development contract award
27th Jun 201312:27 pmRNSBlocklisting
25th Jun 20134:11 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.